Compare GEHC & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEHC | ARES |
|---|---|---|
| Founded | 1892 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1B | 38.4B |
| IPO Year | 2022 | 2014 |
| Metric | GEHC | ARES |
|---|---|---|
| Price | $74.62 | $117.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 15 |
| Target Price | $89.69 | ★ $168.73 |
| AVG Volume (30 Days) | 3.0M | ★ 3.3M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | 0.19% | ★ 4.65% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $20,625,000,000.00 | $4,755,618,000.00 |
| Revenue This Year | $7.06 | N/A |
| Revenue Next Year | $4.50 | $17.59 |
| P/E Ratio | ★ $16.09 | $78.35 |
| Revenue Growth | 4.84 | ★ 28.86 |
| 52 Week Low | $59.95 | $95.80 |
| 52 Week High | $89.77 | $195.26 |
| Indicator | GEHC | ARES |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 59.33 |
| Support Level | $69.59 | $97.12 |
| Resistance Level | $75.33 | $157.40 |
| Average True Range (ATR) | 1.72 | 5.14 |
| MACD | 0.65 | 2.41 |
| Stochastic Oscillator | 80.29 | 83.01 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ares Management is one of the world's largest alternative-asset managers, with $595.7 billion in total assets under management, or AUM, including $367.6 billion in fee-earning AUM, at the end of September 2025. The company has four main business segments: private credit ($391.5 billion in total AUM and $240.2 billion in fee-earning AUM), private equity, ($25.1 billion/$11.8 billion), real estate/real assets ($132.4 billion/$80.5 billion), and other alternatives ($46.7 billion/$35.1 billion). The firm primarily serves institutional investors (80% of AUM) and high-net-worth individuals (20%). Ares operates through more than 35 offices in over 15 countries around the globe.